Last updated on June 2019

Saline Hypertonic in Preschoolers + CT


Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Cystic Fibrosis
  • Age: Between 3 - 5 Years
  • Gender: Male or Female

Inclusion Criteria:

  1. Diagnosis of CF as evidenced by one or more clinical features consistent with the CF phenotype or positive CF newborn screen AND one or more of the following criteria:
  2. A documented sweat chloride 60 mEq/L by quantitative pilocarpine iontophoresis (QPIT)
  3. A documented genotype with two disease-causing mutations in the CFTR gene
  4. Informed consent by parent or legal guardian
  5. Age 36 months and 72 months at screening visit
  6. Ability to comply with medication use, study visits and study procedures as judged by the site investigator
  7. Ability to cooperate with chest CT at the enrollment visit as determined by the lung function technician

Exclusion Criteria:

  1. Chest CT within 8 months prior to the Screening visit
  2. Acute intercurrent respiratory infection, defined as an increase in cough, wheezing, or respiratory rate with onset within 3 weeks preceding screening or enrollment visit
  3. Acute wheezing at screening or enrollment visit
  4. Oxygen saturation < 95% (<90% in centers located above 4000 feet elevation) at screening or enrollment visit
  5. Other major organ dysfunction, excluding pancreatic dysfunction
  6. Physical findings that would compromise the safety of the participant or the quality of the study data as determined by site investigator
  7. Investigational drug use within 30 days prior to screening or enrollment visit
  8. Treatment with inhaled HS at any concentration within 30 days prior to screening or enrollment visit
  9. Initiation (i.e. new prescription) of any inhaled hydrating agent such as mannitol or mucolytic agents such as dornase alpha within 30 days prior to the screening or enrollment visit
  10. Chronic lung disease not related to CF
  11. Inability to tolerate first dose of study treatment at the enrollment visit

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.